Revenue

A burgeoning market for cervical dystonia is set for disruption. A pipeline of novel therapies, including oral options, promises to address unmet patient needs.

FDA clearance for Pulmera's CBeam platform could democratize surgery by turning standard 2D X-ray machines into advanced 3D imagers, slashing costs.

Ainekko is open-sourcing its advanced AI silicon design, betting that a collaborative ecosystem can outmaneuver the proprietary giants of edge computing.

A new collaboration between Coherix and Kawasaki Robotics promises to end manufacturing defects by using AI to fix errors before they even happen.

A generational shift is underway as Millennials and Gen Z flock to the pre-owned luxury watch market, armed with data and viewing timepieces as tangible investments.

YouTube's culinary star Andrew Rea partners with CookUnity, trading views for plates. A deep dive into a model that could redefine creator-led commerce.

Kot Auto Group's latest acquisition isn't just about selling more cars. It's about building the centralized physical and service network for our automotive future.

With AI poised to dominate enterprise communication, a startup's $10M seed round bets its 'pre-send' firewall can solve a $2.2 billion regulatory headache.

As ad dollars flood Connected TV, marketers grapple with a chaotic sea of fragmented data. A new AI platform, Kortex, promises a unified map to ROI.

Health Union's latest awards aren't just for recognition. They're building a new strategic infrastructure for patient influence, complete with certifications.

Gartner’s latest report signals a seismic shift in cybersecurity. We unpack the move from reactive defense to preemptive strikes, and why it's now essential.

Ottawa's record sport investment isn't just about soccer; it's a diversified portfolio play. We analyze the capital allocation and expected returns.

A landmark Canada-South Korea deal for LNG, crude, and critical minerals offers a new blueprint for de-risking supply chains and creates major opportunities for investors.

A Florida firm's record mulch deliveries are more than just good news; they're a data-backed blueprint for the future of sustainable materials.

With a fresh $31M, Advanced NanoTherapies is advancing a first-of-its-kind dual-drug nanoparticle balloon, a technology poised to disrupt the market.

A biometric breakthrough promises to solve crimes faster than ever. But as AI closes cold cases, it opens a Pandora's box of ethical and privacy questions.

Industrial AI leader Seeq is moving beyond mere analytics. At Conneqt 2026, it unveiled a vision to codify expertise into a new corporate asset class.

Quoin Pharmaceuticals files the first-ever drug application for Peeling Skin Syndrome, offering a glimmer of hope for patients with no treatment options.

The $320B tokenized asset market is notoriously illiquid. Symbiotic's Liquid Lane aims to change that with a novel shared collateral model for instant redemptions.

As the Pentagon plans a 200,000-drone fleet, one small firm is making a big play. Mobilicom's pitch to top investors reveals a critical new frontline: cybersecurity.